Annual Report • Mar 31, 2017
Annual Report
Open in ViewerOpens in native device viewer
The investment objective of SVM UK Emerging Fund PLC (the "Fund" or the "Company") is long term capital growth from investments in smaller UK companies. Its aim is to outperform the IMA UK All Companies Sector Average Index on a total return basis.
| Year to 31 March 2017 |
Year to 31 March 2016 |
||||
|---|---|---|---|---|---|
| Total Return performance: | |||||
| Net Asset Value total return | +15.7% | +8.1% | |||
| Share Price total return | +8.0% | +5.9% | |||
| Benchmark Index (IMA UK All Companies Sector Average Index since 1 October 2013*) |
+18.3% | –2.5% | |||
| 31 March 2017 |
31 March 2016 |
% Change | |||
| Capital Return performance: | |||||
| Net asset value (p) | 94.25 | 81.47 | +15.7% | ||
| Share price (p) | 67.50 | 62.50 | +8.0% | ||
| FTSE All-Share Index | 3,990 | 3,395 | +17.5% | ||
| Discount | 28.4% | 23.3% | |||
| Gearing*** | 23.8% | 25.2% | |||
| Ongoing Charges ratio: | |||||
| Investment management fees** | – | – | |||
| Other operating expenses | 1.3% | 1.2% | |||
| Total Return to | 1 | 3 | 5 | 10 | Launch |
| 31 March 2017 (%) | Year | Years | Years | Years | (2000) |
| Net Asset Value | +15.7 | +47.6 | +31.9 | +37.5 | –2.8 |
| Benchmark Index* | +18.3 | +30.9 | +32.3 | +51.8 | –28.8 |
*The benchmark index for the Fund was changed to the IMA UK All Companies Sector Average Index from 1 October 2013 prior to which the FTSE AIM Index was used.
**The Manager has waived its management fees for the year to 31 March 2017 and 2016.
*** The gearing figure indicates the extra amount by which shareholders' funds would change if total assets (including CFD position exposure and netting off cash and cash equivalents) were to rise or fall. A figure of zero per cent means that the Company has a nil geared position.
Over the 12 months to 31 March 2017, the share price gained 8.0%. Since the current joint managers were appointed in September 2012, net asset value has risen 97.0%, versus a benchmark return of 48.3% (total return).
The Company's share price and net asset value continued to progress in the two months since the year end and were 74.5p and 103.52p, respectively at 31 May 2017.
Political and economic change created a challenging backdrop to the year under review. In June 2016, the Brexit vote triggered a fall in the Pound and weakness in shares of many domestically-oriented businesses. As the portfolio tends to be more exposed to UK earnings than the FTSE 100 or FTSE All-Share indices, this did not help performance. Then, in the closing months of 2016, inflation began to pick-up, focusing investor interest in mining, oil and banks. As your Company focuses on investing in growing medium sized and smaller companies, it has little exposure to these cyclical global businesses. In more recent months, however, this market pattern has changed, with political and macro-economic headwinds easing. Most companies in the portfolio are reporting good earnings progress, and investor interest has returned to recognise their inherent business strengths.
The most significant contributions to performance came from Fevertree Drinks, Burford Capital, 4Imprint Group, ASOS and Hutchison China Meditech. The Fund has above average investment in healthcare, technology, business services, travel and gaming.
During the year, new investments were made in specialist property developer,
Watkin Jones, and in radiology group, Medica. Additional investments were made in Clinigen, Melrose and Mattioli Woods. To fund these, Shire Pharmaceuticals, Sage, Compass and Imperial Brands were sold. This cut in FTSE 100 exposure in favour of growing mid cap businesses recognises the opportunities a number of medium sized
companies currently have, and follows encouraging recent meetings with management.
The Fund focuses on companies where there are self-help opportunities or potential for acquisition, such as Kerry Group, RPC, Micro Focus and DCC. The portfolio also includes businesses where there are good prospects for pricing improvement and volume recovery, such as Polypipe and construction engineering group, Severfield.
The Annual General Meeting will be held on 15 September 2017 at SVM's offices in Edinburgh. At the last General Meeting, shareholders approved powers for the Company to issue shares and to buy back for cancellation, or to hold in treasury. Your Board has directed the Manager to implement this arrangement, operating within Board guidelines and approvals.
This aims to improve liquidity in our shares, and your Board ensure that this overall is not dilutive to shareholders.
Although Brexit has created some uncertainty in the short term for the UK, the economy is proving resilient. The fall in the Pound has assisted exporters and boosted tourism, with the Bank of England continuing to assist bank lending and housing. There are signs that the Eurozone is returning to growth, which will help many portfolio companies.
Despite the uptick in global growth, debt has been increasing in many nations. This will bring disinflationary pressures in the medium term despite the current respite. With technology maintaining pressure on margins, there remain longer term headwinds for some cyclical sectors. The environment favours businesses with genuine organic growth and some pricing power.
While the UK economy is not growing as fast as the US or Eurozone, it is surprisingly robust and offers a good environment for many portfolio companies. For most, the outlook is also helped by the strengthening global economy. The portfolio emphasises scalable businesses operating in niches
where they have an edge that can protect margins and deliver above average growth. Your Company remains fully invested.
Peter Dicks Chairman
30 June 2017
The Fund continued its strong recovery since 2012 in the 12 months to 31 March 2017. Net asset value increased by 15.7%, versus 18.3% in the benchmark, the IA UK All Companies Sector Average. Since the current investment managers, Margaret Lawson (lead manager) and Colin McLean, assumed portfolio responsibility, net asset value has risen 97.0%, versus a benchmark return of 48.3% (total return). The Company's share price and net asset value continued to progress in the two months since the year end.
Performance over the year was broadly based across a range of medium sized growth businesses. Many of the successful portfolio companies operate scalable business models, making use of outsourcing and external capital. Fevertree Drinks has emerged as a major provider of premium mixers in the UK, but focuses on branding and distribution, delegating manufacturing to others. Fevertree is broadening its range beyond gin mixers, and its strategy is also to expand internationally. Online retailer, ASOS, has built strengths in its website offering and delivery, and has potential to grow its market
share at the expense of high street retailers. Hutchison China Meditech (Chi-Med) has a research opportunity in China to develop cancer treatments, in association with major global pharmaceutical groups. Chi-Med has used the profitability of its consumer pharmaceutical division to finance this to date, but it has added a US listing to its UK AIM listing, to expand its potential to raise finance for drug development in future. These three companies are amongst the largest listed on London's Alternative Investment Market, but have been able to grow significantly without a full listing.
Another portfolio theme is the potential for self-help in companies – where management can restructure, acquire or cut costs to add shareholder value. Johnson Service Group sold its dry cleaning division, allowing it to focus on restaurant, hotel and workwear services, which have attractive profit margins and growth potential. GVC Holdings acquired competitor, Bwin, in 2016 and should be able to enhance growth as well as make some cost savings as the businesses are merged. A number of other businesses in the portfolio, such as Rentokil and wealth manager, Mattioli Woods, have similar potential for adding to their organic growth via selective acquisitions. There were relatively few disappointments during the year, but the higher oil price and terrorist attacks and terrorism in France adversely impacted Easyjet. ITV and Restaurant Group fell after the Brexit vote raised concerns about UK consumer confidence.
Watkin Jones develops and manages student accommodation. However, it sells the developed properties on to institutional investors, allowing it to recover capital and separately to win attractive management contracts. We believe its growth outlook is strong, and it has the potential to return some capital to investors. Eve Sleep, which was bought in May 2017, serves consumer markets online, disrupting high street operators. The portfolio also holds online businesses; Hostelworld, FreeAgent, Moneysupermarket, dotDigital Group and Learning Technologies Group.
New investments were made in a number of smaller and medium sized businesses during the year, funded by sales of larger companies. This recognised the resilience of the British economy, and potential for some companies to benefit from the lower level of the Pound. Sales included Reckitt & Benckiser, Glanbia, Imperial Brands, Sage Holdings, Compass and Travis Perkins. New investments included litigation finance specialist, Burford Capital, media consultant, Ascential, and Vectura Medical. Additions were made to Hutchison China Meditech, radiology services provider, Medica Group, Melrose and Clinigen. Although the portfolio is spread across a range of sectors, the emphasis is on healthcare, technology, business services, travel and gaming. There are no portfolio investments in banks, oil & gas or mining. Those sectors are dominated by large global businesses, more subject to competition and impact of the economic cycle.
Last year, investor attention focused on inflation prospects, and sectors that might benefit such as banks, oil and miners. But in 2017, it is clearer that much of the global inflation boost came from the oil price alone, boosted by OPEC production cuts. Inflation has not yet become embedded in wages and may not spiral to higher levels. Bond markets still reflect a belief that inflation will be subdued in the longer term. Disinflationary forces of technology and low productivity growth continue to constrain real wage growth globally.
New business models are emerging that are disrupting some traditional sectors and large established companies. Scale and brands
may not be sufficient to protect some older businesses in sectors such as retailing, banking and finance. The portfolio includes a number of the newer disruptive businesses with significant growth potential. There is a spread of holdings to recognise risks that individual companies may face in creating these new strategies. To date, this approach has been rewarding for the Company.
Meetings with company managements continue to be encouraging, and portfolio companies are making good progress. We see considerable investment opportunity and accordingly the Fund is fully invested.
| Stock | Market Exposure 2017 £000 |
% of Net Assets |
Market Exposure 2016 £000 |
|
|---|---|---|---|---|
| 1 | 4Imprint Group | 272 | 4.8 | 196 |
| 2 | Fevertree Drinks | 259 | 4.6 | 114 |
| 3 | Johnson Service Group | 244 | 4.3 | 223 |
| 4 | GVC Holdings | 197 | 3.5 | 135 |
| 5 | Burford Capital | 190 | 3.4 | – |
| 6 | Paddy Power Betfair | 166 | 2.9 | 251 |
| 7 | ASOS | 162 | 2.9 | 87 |
| 8 | Hutchison China Meditech | 158 | 2.8 | 139 |
| 9 | Hikma Pharmaceuticals | 152 | 2.7 | 200 |
| 10 | Unite Group | 149 | 2.6 | 193 |
| Ten largest investments | 1,949 | 34.5 | ||
| 11 | Redrow | 143 | 2.5 | 112 |
| 12 | Supergroup | 141 | 2.5 | 135 |
| 13 | Beazley Group | 134 | 2.4 | 113 |
| 14 | Kerry Group | 131 | 2.3 | 99 |
| 15 | Workspace Group | 130 | 2.3 | 130 |
| 16 | JD Sports | 122 | 2.2 | 71 |
| 17 | ITV Television | 122 | 2.2 | 275 |
| 18 | Ryanair | 120 | 2.1 | 66 |
| 19 | FDM Group | 118 | 2.0 | 95 |
| 20 | UDG Healthcare | 115 | 2.0 | – |
| Twenty largest investments | 3,225 | 57.0 | ||
| 21 | Hill & Smith | 114 | 2.0 | – |
| 22 | Ted Baker | 110 | 1.9 | 142 |
| 23 | Dotdigital Group | 103 | 1.8 | – |
| 24 | Melrose | 94 | 1.7 | – |
| 25 | Restaurant Group | 93 | 1.6 | – |
| 26 | GB Group | 91 | 1.6 | – |
| 27 | Dechra Pharmaceuticals | 90 | 1.6 | – |
| 28 | Watkin Jones | 90 | 1.6 | – |
| 29 | Rentokil | 89 | 1.6 | – |
| 30 | Eco Animal Health Group | 89 | 1.6 | – |
| Thirty largest investments | 4,188 | 74.0 | ||
| Other investments (50 holdings) | 2,626 | 46.4 | ||
| Total Investments | 6,814 | 120.4 | ||
| CFD positions exposure | (1,342) | (23.7) | ||
| CFD unrealised gains | 111 | 2.0 | ||
| Net current assets | 77 | 1.3 | ||
| Net assets | 5,660 | 100.0 |
Market exposure for equity investments held is the same as fair value and for CFDs held is the market value of the underlying shares to which the portfolio is exposed via the contract. Further information is given in note 5 to the financial statements. A full portfolio listing as at 31 March 2017 is detailed on the website.
The Directors submit the Strategic Report for the year to 31 March 2017. The information set out on pages 2 to 13, including the Chairman's Statement and the Manager's Review, forms part of the Strategic Report.
The investment objective of the Fund is long term capital growth from investments in smaller UK companies. Its aim is to outperform the IMA UK All Companies Sector Average Index on a total return basis.
The Fund aims to achieve its objective and to diversify risk by investing in shares and related instruments, controlled by a number of limits on exposures. Appropriate guidelines for the management of the investments, gearing and financial instruments have been established by the Board. Limits are expressed as percentages of shareholders' funds, measured at market value.
Although the benchmark is the IMA UK All Companies Sector Average Index, the pursuit of the investment objective may involve exposure to companies on various exchanges and to unlisted investments. A high conviction investment approach is employed, which can involve strong sector or thematic positions.
No individual investment will exceed 10% of the portfolio on acquisition. Total exposure to unlisted shares is also limited to a maximum of 25% of the portfolio and has historically been less.
The Fund has the ability to borrow money to enhance returns. This gearing can enhance benefits to shareholders but, if the market falls, losses may be greater. The level of gearing, including the use of derivatives, is
closely monitored and the Board has set an upper limit of 30% of net assets. Borrowing is normally on a short term basis to ensure maximum flexibility but it may also commit to longer term borrowing. It may also sell parts of the share portfolio and hold cash or other securities when there may be a greater risk of falling stock markets.
The Board has granted the Manager a limited authority to invest in Contracts for Differences (''CFDs'') (long positions) and similar instruments as an alternative to holding actual stocks. This means that the gross cost of investment is not incurred. The total effect of such gearing (bank borrowings plus the gross exposure of long positions less any hedging) is limited to 30% of the Fund's net asset value. Additional limits have also been set on individual hedging to assist risk control. The use of CFDs can involve counterparty credit risk.
The Fund may also make use of hedging as an additional investment tool. To help reduce the potential for stock market weakness to adversely impact the portfolio, the Board has granted the Manager limited authority to hedge risks, within specified limits and to a maximum of 15% of the total portfolio. Such hedging (short positions) may be conducted through CFDs or other index instruments. Hedging can be used to facilitate adjustment of the portfolio at a time of economic uncertainty or increased risk. It aids flexibility and can allow exposure to a sector to be reduced with less disruption to the underlying long term portfolio. However, in a rising stockmarket, this may impact performance.
The Fund does not normally invest in fixed rate securities other than securities that are convertible into equity. However, the Fund may invest in short dated Government Securities as an alternative to holding cash.
The Fund is an investment trust which invests in accordance with its objective and investment policy as set out above. It has no employees and outsources the management of its investment portfolio to the Manager, SVM Asset Management Limited. The Board of the Fund is ultimately responsible for the stewardship of the Company's affairs and risks, acting in the interests of shareholders.
The Fund is required to comply with the Companies Act, the UK Listing Rules and applicable accounting standards. In addition to the formal annual financial statements, interim accounts and interim management statements, it publishes monthly asset values and quarterly factsheets.
The Directors consider a number of key performance indicators ("KPIs") to measure the Fund's success in achieving its objectives. The KPIs used to measure the performance and development of the Fund are the Net Asset Value ("NAV") and share price performance and the rating. The Board assesses these on a regular basis. Further information on these indicators is detailed in the Highlights page, Chairman's Statement, the Manager's website www.svmonline.co.uk and quarterly factsheets. The Board also reviews the performance of the Fund against its peers.
| Historical record Year to 31 March |
NAV per Share (p) |
Share Price (p) |
Total Return (p) |
Rating Discount/(Premium) |
|---|---|---|---|---|
| 2007 | 63.57 | 62.50 | 14.12 | 1.7% |
| 2008 | 65.50 | 67.50 | 1.93 | (3.1)% |
| 2009 | 44.73 | 31.00 | (20.77) | 30.7% |
| 2010 | 68.53 | 50.00 | 23.80 | 27.0% |
| 2011 | 87.36 | 63.00 | 18.83 | 27.9% |
| 2012 | 71.47 | 55.00 | (15.89) | 23.0% |
| 2013 | 53.90 | 43.00 | (17.57) | 20.2% |
| 2014 | 73.93 | 57.75 | 20.03 | 21.9% |
| 2015 | 75.38 | 59.00 | 1.45 | 21.7% |
| 2016 | 81.47 | 62.50 | 6.09 | 23.3% |
| 2017 | 94.25 | 67.50 | 12.78 | 28.4% |
The total gain for the year of £768,000 (2016: gain of £366,000) has been transferred to reserves. No dividend has been declared. The net asset value total return was 15.7% for the year. At 31 March 2017, the net asset value per share was 94.25p and the share price was 67.50p. The Chairman's statement and Manager's review include a review of the main developments during the year.
A detailed analysis of the Fund's portfolio is provided on the page entitled 'Investment Portfolio'.
The Directors review policies for identifying and managing the principal risks faced by the Fund.
Many of the Fund's investments are in small companies and may be seen as carrying a higher degree of risk than their larger counterparts. These risks are mitigated through portfolio diversification, in-depth analysis, the experience of the Manager and a rigorous internal control culture. Further information on the internal controls operated for the Fund is detailed in the Report of the Directors.
The principal risks facing the Fund relate to the investment in financial instruments and include market, liquidity, credit and interest rate risk. An explanation of these risks and how they are mitigated is explained in note 9 to the financial statements. Additional risks faced by the Fund are summarised below:
Investment strategy – The risk that an inappropriate investment strategy may lead to the Fund underperforming its benchmark, for example in terms of stock selection, asset allocation or gearing. The Board have given the Manager a clearly defined investment mandate which incorporates various risk limits regarding levels of borrowing and the
use of derivatives. The Manager invests in a diversified portfolio of holdings and monitors performance with respect to the benchmark. The Board regularly reviews the Fund's investment mandate and long term strategy.
Discount – The risk that a disproportionate widening of discount in comparison to the Fund's peers may result in loss of value for shareholders. The discount varies depending upon performance, market sentiment and investor appetite. The Board regularly reviews the discount and the Fund operates a share buy-back programme.
Accounting, Legal and Regulatory – Failure to comply with applicable legal and regulatory requirements could lead to a suspension of the Fund's shares, fines or a qualified audit report. In order to qualify as an investment trust the Fund must comply with section 1158 of the Corporation Tax Act 2010 ("CTA"). Failure to do so may result in the Fund losing investment trust status and being subject to Corporation Tax on realised gains within the Fund's portfolio. The Manager monitors movements in investments, income and expenditure to ensure compliance with the provisions contained in section 1158. Breaches of other regulations, including the Companies Act 2006, the Listing Rules of the UK Listing Authority or the Disclosure and Transparency Rules of the UK Listing Authority, could lead to regulatory and reputational damage. The Board relies on the Manager and its professional advisers to ensure compliance with section 1158 CTA, Companies Act 2006 and UKLA Rules.
Operational – The risk of loss resulting from inadequate or failed internal processes, people and systems or from external events. Like most other Investment Trusts, the Fund has no employees and relies upon the services provided by third parties. The Manager has comprehensive internal
controls and processes in place to mitigate operational risks. These are regularly monitored and are reviewed to give assurance regarding the effective operation of the controls.
Corporate Governance and Shareholder Relations – Details of the Fund's compliance with corporate governance best practice, including information on relations with shareholders, are set out in the Directors' Statement on Corporate Governance.
Financial – The Fund's investment activities expose it to a variety of financial risks including market, credit and interest rate risk. These risks are explained in note 9 to the financial statements. The Board seeks to mitigate and manage these risks through continuous review, policy setting and enforcement of contractual obligations. The Board receives both formal and informal reports from the Manager and third party service providers addressing these risks. The Board believes the Fund has a relatively low risk profile as it has a simple capital structure; invests principally in UK quoted companies; does not use derivatives other than CFDs and uses well established and creditworthy counterparties.
The capital structure comprises only ordinary shares that rank equally. Each share carries one vote at general meetings.
The Directors have assessed the viability of the Company over the period of five years and consider that an appropriate period given the Company's investment objective, strategy and business model. The assessment has taken account of the Company's position, its investment objective and strategy, its ability to settle projected liabilities of the Company as they fall due and the potential impact of the relevant principal risks detailed above. Based on this assessment, the Directors have a reasonable expectation that the Company will be able to continue in operation and meet
its liabilities as they fall due over the five year period, subject to the Company's Shareholders continuing to support it and in particular voting in favour of the continuation of the Company in 2020.
The Directors of the Fund at 31 March 2017, all of whom held office throughout the year, are set out on the page entitled 'Board of Directors' which contains biographies. The Board consists of 3 male Directors. The Fund does not have any employees.
As an investment trust, the Fund has no direct responsibilities in respect of these matters, however, the Directors recognise that encouraging investee companies to recognise these responsibilities can have positive implications for shareholder value. Further information on governance responsibilities, including environmental, is included in the Directors' Statement on Corporate Governance contained in the Directors' Report.
The Board's main focus is to achieve long term capital growth. The future performance of the Fund is dependent on the success of the investment strategy and the performance of economic and financial markets. The current outlook for the Fund is referred to in the Chairman's Statement and Manager's Review. The Board's intention is that the Fund will continue to pursue its investment objective and stated investment policy.
By Order of the Board,
30 June 2017
Peter Dicks (Chairman) Richard Bernstein Anthony Puckridge
Peter Dicks was a founder and director of Abingworth plc which, between 1973 and 1992, specialised in making venture capital investments in the USA and the UK. He is currently a director of ICG Enterprise Trust Plc, Unicorn AIM VCT plc, Mears Group plc, Foresight VCT range of funds and a number of other quoted and unquoted companies. Mr Dicks has served on the Board for over nine years and stands for annual re-election.
Richard Bernstein, a chartered accountant, is the founder and Chief Executive of Eurovestech plc, which he founded in 2000. Between 1994 and 1996, he ran his own specialist research house, Amber Analysis, which provided a risk management service for UK institutions. From 1996 until 1999, he was an equities analyst at Schroder Securities Limited. He has considerable investment experience with listed investments. Since 2008, Richard has been the Investment Adviser to Crystal Amber Fund. Mr Bernstein has served on the Board for over nine years and stands for annual re-election.
Anthony Puckridge is a director of NW Brown and Company Limited, a broadly diversified financial business where he founded the investment management division. Prior to joining NW Brown, he was a director of Lazard Brothers & Co Limited where at various times he managed and advised pension funds, was in charge of both the US and smaller companies investments and was responsible for a series of funds involved in making venture capital investments. He is a Member of the Securities Institute. Mr Puckridge has served on the Board for over nine years and stands for annual re-election.
The Directors submit the Annual Report and Financial Statements for the year to 31 March 2017.
The Fund is an Investment Company as defined in Section 833 of the Companies Act 2006 (company number: SC211841). It is not a close company for taxation purposes. It has been approved by HM Revenue & Customs as an investment trust subject to the Fund continuing to meet the eligibility conditions in section 1158 of Corporation Tax Act 2010 and the ongoing requirements for approved companies. In the opinion of the Directors, the Fund has subsequently conducted its affairs so as to enable it to continue to obtain such approval. The Company is registered as a small UK Alternative Investment Fund Manager under the Alternative Investment Fund Managers Regulations 2013.
Other than the information contained within the Directors' Remuneration Report relating to the Directors waiving part of their fees, there are no other instances where the Company is required to make disclosures in respect of Listing Rule 9.8.4R.
The Directors who held office during the year and their beneficial interests in the ordinary shares of the Fund were:
| 31 March 2017 |
31 March 2016 |
|
|---|---|---|
| P F Dicks | 272,500 | 250,000 |
| R P Bernstein | 142,500 | 120,000 |
| A Puckridge | 50,000 | 40,000 |
There have been no changes in the Directors' interests between 31 March 2017 and 30 June 2017.
Each Director has a letter of appointment, details of which are noted in the Directors' Remuneration Report.
Each Director, having served for more than nine years, will offer himself for re-election at the Annual General Meeting. The Board considers that each Director is independent, despite having served on the Board for more than nine years and have demonstrated their independence through integrity and a robust contribution. The Board is of the view that length of service does not necessarily compromise the independence or contribution of directors of an investment trust, where continuity and experience can add significantly to the strength of the Board. The Board considers the long service of the Directors as an asset and recommends their individual re-election to shareholders.
SVM Asset Management Limited provides investment management and secretarial services to the Fund. These services can be terminated without compensation at any time by giving one year's notice or an immediate payment of a year's fees in lieu of notice. The Manager is entitled to a fee for these services, payable quarterly in arrears, equivalent to 0.825 per cent per annum of the total assets of the Fund less current liabilities. In addition, SVM Asset Management Limited is entitled to an incentive fee of 15 per cent of achieved outperformance of the Fund's benchmark index, on a six monthly basis in arrears when the net asset value of the Fund exceeds 100p. In view of the size of the Fund, the Manager has waived its management fees for the years to 31 March 2017 and 2016. No incentive fee was paid or due in respect of the years to 31 March 2017 or 31 March 2016.
The Management and Nomination Committee assess the Manager's performance on an ongoing basis and meet each year to conduct a formal evaluation of the Manager. It assesses the resources made available by the Manager, the results and investment performance in relation to the Fund's objectives and also the additional services provided by the Manager to the Fund.
The Committee has reviewed the Manager's contract. In carrying out its review, it considered the past investment performance and the Manager's capability and resources to deliver superior future performance. It also considered the length of the notice period of the investment management contract and the fees payable together with the standard of other services provided which include secretarial, accounting, marketing and risk monitoring. Following this review, it is the Directors' opinion that the continuing appointment of the Manager on the terms agreed is in the best interests of the shareholders.
As at 30 June 2017, the following interests in excess of 3 per cent of the issued ordinary shares of the Fund had been reported:
| Number of Shares held |
Percentage held |
|
|---|---|---|
| SVM Asset Management Limited and client |
||
| holdings* | 1,749,932 | 29.1% |
| C W McLean* | 370,000 | 6.2% |
| Charles Stanley & & Co, Rock (Nominees) Ltd |
327,800 | 5.5% |
| Alexander Moffat & Co WS |
305,000 | 5.1% |
| Armstrong Investments Limited |
300,000 | 5.0% |
| Stephen James Blackford & Mrs Tracey Magdeline Blackford |
296,000 | 4.9% |
| Peter Dicks | 272,500 | 4.5% |
*The reported shareholding of C W McLean is also included in the reported shareholding of SVM Asset Management Limited.
The Fund's financial instruments comprise the investment portfolio (including the use of CFDs), cash at bank and on deposit, bank overdrafts and debtors and creditors that arise directly from operations. The main risks that the Fund faces from its financial instruments are disclosed in note 9 to the financial statements.
The rights and obligations attaching to the Funds ordinary shares are set out in the Fund's Articles of Association. The ordinary shares carry the right to receive any dividends and have one voting right per share. There are no restrictions on voting rights of the shares or the transfer of shares, and there are no shares that carry specific rights with respect to control of the Fund.
The Directors are seeking authority to allot ordinary shares up to an aggregate nominal amount of £30,000 and authority to sell shares held in treasury as set out in Resolutions 8 and 10 of the Notice of the Annual General Meeting.
The Directors believe this authority can improve liquidity in the Company's shares and will only issue shares pursuant to this authority if they believe it is advantageous to the Fund's existing shareholders to do so.
The current authority of the Fund to make market purchases expires on the conclusion of this year's Annual General Meeting. Resolution 9, as set out in the Notice of the Annual General Meeting, seeks renewal of this authority to make market purchases of up to 10% of the issued ordinary shares. The price paid for shares will not be less than the nominal value of 5 pence per share nor more
than 5% above the average of the market values of these shares for the five business days before the shares are purchased. This power will only be exercised if, in the opinion of the Directors, a repurchase would be in the best interests of the shareholders as a whole.
Any shares purchased under this authority will either be cancelled or held in treasury for future re-sale in appropriate market conditions.
The Board, having made appropriate enquiries, has a reasonable expectation that the Fund has adequate resources to continue in operational existence for the foreseeable future a period of not less than 12 months from the date of the this report. At the Annual General Meeting to be convened in 2020 and every five years thereafter, shareholders will be given the opportunity to decide on the future of the Fund. In assessing whether it is a going concern, the Board has considered the current cash position and the overall financial position of the Fund. For these reasons, the Board considers that there is reasonable evidence to continue to adopt the going concern basis in preparing the financial statements.
The Board of Directors considers that the Fund has complied with the recommendations of the AIC's Code of Corporate Governance and the provisions of the Financial Reporting Council's UK Corporate Governance Code (the "Code'') that are relevant to the Fund throughout the year except as noted below:
• the role of the chief executive;
Therefore, those issues on which the Fund does not report in detail are excluded because the Board deems them to be irrelevant to the Fund as explained in the AIC's Code of Corporate Governance.
The Directors confirm that the Fund has complied with the requirement to be headed by an effective Board to lead and control it. The Fund is an investment trust and not a trading company and, as such, there is no requirement for a Chief Executive Officer. The Board consists solely of non-executive Directors. Mr Peter Dicks is the Chairman and Mr Anthony Puckridge is the Senior Independent Director. All Directors are considered by the Board to be independent of the Manager and free from all business or other relationships that could interfere with the exercise of their independent judgement.
Whilst the Directors are not appointed for specific terms, as required by the Code, all the Directors must submit themselves for reelection by the shareholders annually and are not entitled to compensation if they are not reelected to office.
Since all Directors are non-executive, the Fund is not required to comply with the principles of the Code in respect of executive Directors' remuneration. Directors may seek independent professional advice if necessary, at the expense of the Fund.
The Directors conduct an annual selfassessment of their collective and individual performances on a range of issues to review the effectiveness of the Board, the Committees and individual Directors in order to ensure that they are acting in the best interests of the Fund and its shareholders. In addition, the performance of the Chairman is
evaluated by the other Directors. Having reviewed these assessments, it is the Board's opinion that each Director's performance continues to be effective and to demonstrate commitment to their role.
The table below sets out the number of Board meetings, Audit Committee and, Management and Nomination Committee meetings held during the year and the meetings attended by each Director.
The Manager maintains regular contact with the Fund's shareholders, particularly institutional shareholders, and reports regularly to the Board on shareholder relations. In addition, the Board uses the Annual General Meeting as a forum for shareholders to meet and discuss issues with the Board and the Manager.
A management agreement between the Fund and the Manager sets out the matters over which the Manager has authority and the limits over which Board approval must be sought. All other matters, including corporate strategy, investment policy, corporate governance procedures, risk management and principal operating issues such as hedging, gearing, share issuance and buy backs are reserved for the approval of the Board. Details of the limits set on the key areas are set out in the Financial Instruments disclosures in note 9 to the financial statements.
The Fund usually exercises its voting powers at general meetings of investee companies. It does not operate a fixed policy when voting but treats each case on merit. The Manager has adopted the statement of principles set out by the Institutional Shareholders' Committee on the Responsibilities of Institutional Shareholders and Agents.
The Board recognises that corporate, social, environmental and ethical responsibility enables good sustainable business growth and can have positive implications for shareholder value. The Board believes that encouraging companies to recognise these responsibilities is best achieved with dialogue and actively aiming to encourage best practice. The Board notes the Manager's statement of compliance with the UK Stewardship Code issued by the Financial Reporting Council in July 2010, which can be found on the Manager's website www.svmonline.co.uk
Each Director has a statutory duty to avoid a situation where they (and connected persons) have, or could have, a direct or indirect interest which conflicts, or may conflict, with the interests of the Fund. The Board has in place procedures for identifying and dealing with conflicts or potential conflicts. No actual or potential conflicts were identified during the year.
| Board | Audit Committee |
Management and Nomination Committee |
|
|---|---|---|---|
| Number of meetings held in year |
4 | 2 | 2 |
| P F Dicks | 3 | 1 | 1 |
| R P Bernstein | 4 | 2 | 2 |
| A Puckridge | 4 | 2 | 2 |
Amendment of the Fund's Articles of Association requires a special resolution to be passed by shareholders.
The Board has adopted a formal schedule of matters specifically reserved to itself for decision and, in relation to certain matters, two committees (the Audit Committee, and the Management and Nomination Committee) have been established. Each of the committees comprises all of the Directors. The Board considers that it is appropriate for all Directors to be members of these committees, given the size and composition of the Board.
Both committees are chaired by the Senior Independent Director. The terms of reference of both committees are available for inspection on request from the Managers. Further information on the role of the Audit Committee is set out in the Audit Committee Report.
The Management and Nomination Committee, which comprises all of the independent Directors and for which a quorum is any two of the independent Directors, meets at least once a year. Its remit includes such matters as reviewing all contracts for services delivered to the Fund, reviewing and recommending new appointments to the Board and fixing the remuneration of the Directors. In considering appointments to the Board, the Management and Nomination Committee takes into account the ongoing requirements of the Fund and the need to have a balance of skills, experience, diversity (including gender), and independence and knowledge of the Fund and, where appropriate, actively searches for candidates. All appointments are based on merit and therefore no diversity targets have been set against which to report.
As required by section 418 of the Companies Act 2006 each Director of the Fund confirms that:
Scott-Moncrieff has expressed their willingness to continue in office as the Fund's Auditor and a resolution proposing their reappointment and authorising the Directors to determine their remuneration for the ensuing year will be proposed at the forthcoming Annual General Meeting.
The Board is responsible for establishing and maintaining the Fund's system of internal control and reviewing its effectiveness. The UK Corporate Governance Code states that the review should cover all material controls, including financial, operational and compliance controls. The Board, in conjunction with the Manager, has established a process for identifying, evaluating and managing the significant risks faced by the Fund. This process is subject to regular review by the Board and accords with the Financial Reporting Council guidance. The process has been in place for the year under review and up to the date of these financial statements. Internal control systems are designed to meet the particular needs of the Fund and the risks to which it is exposed and, by their nature, can provide reasonable but not absolute assurance against material misstatement or loss.
The principal elements of the Fund's system of internal controls and the process applied by the Board in reviewing its effectiveness are:
The Board meets every quarter to review the overall business of the Fund and to consider the matters specifically reserved for it to decide upon. At these meetings, the Directors review investment performance of the Fund compared to its benchmark index and in relation to comparable investment trusts. The Directors also review its activities over the preceding quarter to ensure it adheres to its investment policy or, if it is considered appropriate, to authorise any change to that policy. The Board is satisfied that it is supplied in a timely manner with information to enable it to discharge its duties.
The Board has engaged external firms to undertake the investment management, administration, secretarial and custodial activities of the Fund. There are clearly documented contractual arrangements between the Fund and these organisations which define the areas where the Board has delegated authority to them.
The Board receives reports on at least an annual basis detailing the internal control
objectives and procedures adopted by each organisation. The Board's review of these reports allows it to assess the effectiveness of the internal systems of financial control which affect the Fund.
As the Board has engaged external firms to undertake the investment management, secretarial, accounting and custody activities of the Fund, the Fund has no greenhouse gas emissions to report from its operations, nor does it have responsibility for any other emissions producing sources under the Companies Act 2006 (Strategic Report and Directors' Reports) Regulations 2013.
The Company's Articles of Association provide, subject to the provisions of applicable UK legislation, an indemnity for Directors in respect of costs incurred in the defence of any proceedings brought against them by third parties arising out of their positions as Directors, in which they are acquitted or judgement is given in their favour.
Except as noted above, the Fund has complied with the applicable provisions of the Code during the year and up to the date of the approval of the financial statements.
By Order of the Board,
30 June 2017
The Board has prepared this report in accordance with the requirements of the Companies Act 2006. It comprises the Directors' Remuneration Policy Report and the Annual Report on Directors' Remuneration.
The Directors' Remuneration Policy Report will be put to shareholders at the forthcoming Annual General Meeting and, if passed, will apply until it is next put to shareholders for approval, which must be at intervals of not less than three years. The Annual Report on Directors' Remuneration will be put to shareholders at the forthcoming Annual General Meeting and annually thereafter.
The law requires the Auditor to audit certain aspects of the disclosures provided. Where disclosures have been audited, they are indicated as such. The Auditor's opinion is included in their report on the page entitled 'Independent auditor's report'.
The Board's policy is that the remuneration of non-executive Directors should reflect the experience of the Board as a whole, be fair and comparable to that of other investment trusts that are similar in size, have a similar capital structure, and have similar investment objectives. In addition, a number of other factors are considered, including the time commitment required, the level of skills and experience required and any specific responsibilities of Directors. There were no changes to the policy during the year and it is the intention that this policy will continue for the three year period ending at the Annual General Meeting in 2020.
The fees for the non-executive Directors are determined within the limits set out in the
Fund's Articles of Association. The current limit is £75,000 in aggregate per annum and shareholder approval in a general meeting would be required to change this limit. Nonexecutive Directors are not eligible for bonuses, pension benefits, share options, long-term incentive schemes, compensation for loss of office or other benefits.
All Directors were originally appointed at the Fund's inception in 2000 and all Directors have a letter of appointment. These letters are kept and are available for inspection at the Fund's registered office. The terms of their appointment provide that a Director shall retire and be subject to re-election at the first Annual General Meeting following their appointment. Directors are thereafter obliged to retire by rotation, and, if they wish, to offer themselves for re-election, at least every three years thereafter. There is a 3 month notice period and the Fund reserves the right to make a payment in lieu of notice on early termination of appointment. None of the Directors has a service contract with the Fund.
The Board's policy of tenure is to review actively whether Directors with service of nine years or more should be re-nominated, whilst ensuring that the process of refreshing the Board does not compromise a balance of experience, age, length of service and skills.
The Management and Nomination Committee recommends to the Board candidates for nomination as Directors. The Committee seeks candidates with the aim of ensuring that the Board comprises a broad spread of experience and knowledge and, where appropriate, actively searches for candidates. New appointments will receive induction training and spend time with representatives of the Manager. The Fund's policy is to encourage Directors to keep up to date with industry developments relevant to the Fund.
The Fund has three non-executive Directors as detailed on the 'Board of Directors' page, all of whom are independent. The Management and Nomination Committee, comprising of all the Directors, fulfils the function of a Remuneration Committee in addition to its nominations functions. The Board has appointed SVM Asset Management Limited as Company Secretary to provide information when the Management and Nomination Committee consider the level of Directors' fees. The Directors are independent of SVM Asset Management Limited and SVM Asset Management Limited receives no additional fees for the provision of this information. The Management and Nomination Committee carries out a review of the level of Directors' fees on an annual basis. In addition, SVM Asset Management Limited provides investment management, administration and secretarial services to the Fund.
The table below shows the actual expenditure during the year in relation to Directors' remuneration, operating expenses and shareholder distributions. Due to the size of the Fund, the Manager has waived its management fee and the Directors have waived their entitlement to half their fees until further notice.
| 2017 £ |
2016 £ |
Change % |
|
|---|---|---|---|
| Directors' total remuneration |
17,500 | 17,500 | – |
| Operating Expenses |
53,500 | 50,500 | 6%† |
| Dividends paid to shareholders |
Nil | Nil | – |
The Directors who held office during the year and their beneficial interests in the ordinary shares of the Fund were:
| 31 March 2017 £ |
31 March 2016 £ |
|
|---|---|---|
| P F Dicks | 272,500 | 250,000 |
| R P Bernstein | 142,500 | 120,000 |
| A Puckridge | 50,000 | 40,000 |
There have been no changes in the Directors' interests between 31 March 2017 and 30 June 2017. The Board has not adopted a policy whereby Directors are required to own shares in the Fund.
The graph below compares the share price total return (assuming all dividends are reinvested) to Ordinary Shareholders for the last five years (to 31 March 2017) to the total shareholder return on a notional investment made up of shares of the same kinds and number as those by reference to which the IMA UK All Companies Sector Average Index (prior to 1 October 2013 the FTSE AIM Index) is calculated. The Index has been chosen as it represents the Fund's benchmark.
The Directors who served in the year received the following emoluments in the form of fees:
| Fees 2017 £ |
Fees 2016 £ |
|
|---|---|---|
| P F Dicks | 7,500 | 7,500 |
| R P Bernstein | 5,000 | 5,000 |
| A Puckridge | 5,000 | 5,000 |
| Total | 17,500 | 17,500 |
Based on the current level of fees, Directors' remuneration for the forthcoming financial year would be as follows:
| Fees 2018 £ |
Fees 2017 £ |
|---|---|
| 7,500 | 7,500 |
| 5,000 | 5,000 |
| 5,000 | 5,000 |
| 17,500 | 17,500 |
The Fund has not received any views from its Shareholders in respect of the level of Directors' remuneration.
At the Fund's last Annual General Meeting, held on 9 September 2016, shareholders approved the Directors' Remuneration Report in respect of the year ended 31 March 2016. 100% of votes were in favour of the resolution and 0% were against.
Ordinary resolutions for the approval of this report and the Directors' Remuneration Policy Report will be put to the members at the forthcoming Annual General Meeting.
By Order of the Board,
Company Secretary Edinburgh
30 June 2017
The Audit Committee, which comprises all of the independent Directors, meets at least twice a year. All Directors have the requisite financial experience to sit on this committee. Terms of reference set out the role of the Audit Committee. Its role is to review the Fund's financial position, internal controls, scope and results of the audit, its cost effectiveness and the independence and objectivity of the auditor.
The Audit Committee must also satisfy itself that the Annual Report and Financial Statements are fair, balanced and reasonable. The auditor is invited to attend such meetings and report on the results of the audit.
The Audit Committee considers annually the need for an internal audit function. It believes such a function is unnecessary as the Fund has no employees and subcontracts its business to third parties, the principal one of which is the Manager.
The Audit Committee met on two occasions during the year. In the course of its duties, the committee had direct access to Scott-Moncrieff and senior members of the Manager's team. Amongst other things, the Audit Committee considered and reviewed the following matters and reported thereon to the Board:
internal controls operated by the Manager;
effectiveness of the audit process and related non-audit services and the independence and objectivity of Scott-Moncrieff, their re-appointment, remuneration and terms of engagement;
As part of its review of the scope and results of the audit, the Audit Committee considered Scott-Moncrieff's plan for the audit of the financial statements for the year ended 31 March 2017. At the conclusion of the audit Scott-Moncrieff did not highlight any issues to the Audit Committee which would cause it to qualify its audit report nor did it highlight any fundamental internal control weaknesses. Scott-Moncrieff issued an unqualified audit report.
In evaluating the effectiveness of the external audit process, the Audit Committee has taken into consideration the standing, skills and experience of Scott-Moncrieff and the audit team. Working closely with the Manager the Audit Committee considered and evaluated Scott-Moncrieff's planning, scope and execution of the audit.
In relation to the 2017 Annual Report and Financial Statements, the Audit Committee considered a number of issues in relation to the financial statements. The key risk areas identified and how these were addressed were as follows:
• The accuracy of the valuation of the investment portfolio.
Listed investments are valued using stock exchange prices provided by a third party
pricing vendor. CFDs are valued with reference to the investment's underlying bid prices using stock exchange prices provided by a third party pricing vendor. Unlisted investments are valued at fair value based on the latest information available and recommendations from the Fair Value pricing committee of the Manager. The Board reviews portfolio valuations and also relies on controls operated by the Manager in respect of pricing.
The Audit Committee reviews reports from service providers on key controls over the assets of the Fund, including the reconciliation of the Fund's records with those of the custodian of the Fund's assets.
The Board reviews revenue forecasts and receives explanations from the Manager regarding movements from previous forecasts.
The auditor appointment was last put out to tender in 2013 and Scott-Moncrieff was appointed as auditor in place of the incumbent auditor for the audit in respect of the year to 31 March 2014. Based on its review of the effectiveness of Scott-Moncrieff, the Audit Committee has recommended the continuing appointment of Scott-Moncrieff to the Board. Scott-Moncrieff's performance will continue to be reviewed annually taking into account all relevant guidance and best practice.
The auditor has not provided any non-audit services to the Fund other than tax compliance services, for which they are paid £1,000 per annum (2016: £1,000). Notwithstanding these, the Audit Committee has concluded that the auditor is objective and independent. The Audit Committee will continue to monitor on an annual basis the level of non-audit work carried out by the auditor.
Chairman of Audit Committee
30 June 2017
The Directors are responsible for preparing the Annual Report, the Directors' Remuneration Report and the Financial Statements in accordance with applicable law and regulations. Company law requires the Directors to prepare financial statements for each financial year. Under that law, the Directors prepared the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the Directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Fund and of its gain or loss for that period. In preparing these financial statements, the Directors are required to:
The Directors are responsible for keeping adequate accounting records that are sufficient to show and explain the Fund's transactions and disclose with reasonable accuracy at any time the financial position of the Fund and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Fund and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The Directors have delegated responsibility to the Manager for the maintenance and integrity of the Fund's corporate and financial information included on the Manager's website. The work carried out by the Auditor does not involve consideration of these matters and, accordingly, the Auditor accepts no responsibility for any changes that may have occurred to the financial statements since they were initially presented on the website. Legislation in the UK governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
The Directors consider that the Annual Report and Financial Statements, taken as a whole, are fair, balanced and understandable and provide the information necessary for shareholders to assess the Fund's performance, business model and strategy.
The Directors each confirm to the best of their knowledge that:
By Order of the Board
Peter Dicks Chairman
30 June 2017
to the members of SVM UK Emerging Fund plc
We have audited the financial statements of SVM UK Emerging Fund plc for the year ended 31 March 2017, which comprise the Income Statement, the Balance Sheet, the Statement of Changes in Equity, the Cash Flow Statement and the related notes. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including FRS102 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.
This report is made solely to the Company's members as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members as a body, for our audit work, for this report, or for the opinions we have formed.
As explained more fully in the Statement of Directors' Responsibilities on page 26, the Directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. Our responsibility is to audit the financial statements in accordance with applicable law and International Standards on Auditing (UK and Ireland). Those standards require us to comply with the Auditing Practices Board's Ethical Standards for Auditors.
The Directors are responsible for the maintenance and integrity of the corporate and financial information included on the
company's website. Legislation in the United Kingdom governing the preparation and dissemination of the financial statements may differ from legislation in other jurisdictions.
A description of the scope of an audit of financial statements is provided at the Financial Reporting Council's website at www.frc.org.uk/auditscopeukprivate.
We identified the following risks that we believe have the greatest impact on the audit strategy:
We apply the concept of materiality in planning and performing our audit, and in evaluating the effect of misstatements on our audit and on the financial statements. For the purposes of determining whether the financial statements are free from material misstatement we define materiality as the level of error that would change the opinion of the reader of the financial statements.
When establishing our overall audit strategy, we determined the level of uncorrected misstatement that would be material for the financial statements as a whole to be £57,000, which is 1% of net assets (net assets being a key performance indicator for investors in the Company).
Materiality for revenue transactions was determined to be £6,000, as we believe readers of the financial statements will be more sensitive to variances in the revenue account.
We agreed with the Audit Committee that we would report to them individual and extrapolated errors in excess of 5% of the relevant materiality figure, as well as differences below that threshold that we believe warranted reporting on qualitative grounds.
The way in which we scoped our audit in order to address the assessed risks of material misstatement was as follows:
The Audit Committee's consideration of these risks is set out on pages 24 and 25.
In our opinion the financial statements:
• give a true and fair view of the state of the Company's affairs as at 31 March
2017 and of its return for the year then ended;
In our opinion:
We have nothing to report in respect of the following:
Under the International Standards in Auditing (UK and Ireland), we are required to report to
you if, in our opinion, information in the annual report is:
In particular, we are required to consider whether we have identified any inconsistencies between our knowledge acquired during the audit and the Directors' statement that they consider the annual report is fair, balanced and understandable and whether the annual report appropriately discloses those matters that we communicated to the Audit Committee which we consider should have been disclosed.
Under the Companies Act 2006 we are required to report to you if, in our opinion:
Under the Listing Rules we are required to review:
(Senior Statutory Auditor) For and on behalf of Scott-Moncrieff, Statutory Auditor Exchange Place 3 Semple St Edinburgh EH3 8BL 30 June 2017
for the year to 31 March 2017
| Notes | Revenue £000 |
Capital £000 |
Total £000 |
|
|---|---|---|---|---|
| Net gain on investments at fair value | 5 | - | 717 | 717 |
| Income | 1 | 138 | – | 138 |
| Investment management fees | – | – | – | |
| Other expenses | 2 | (64) | (7) | (71) |
| Gain before finance costs and taxation | 74 | 710 | 784 | |
| Finance costs | (17) | – | (17) | |
| Gain on ordinary activities before taxation | 57 | 710 | 767 | |
| Taxation | 3 | 1 | – | 1 |
| Gain attributable to ordinary shareholders | 58 | 710 | 768 | |
| Gain per Ordinary Share | 4 | 0.96p | 11.82p | 12.78p |
| Notes | Revenue £000 |
Capital £000 |
Total £000 |
|
|---|---|---|---|---|
| Net gain on investments at fair value | 5 | – | 317 | 317 |
| Income | 1 | 137 | – | 137 |
| Investment management fees | – | – | – | |
| Other expenses | 2 | (59) | (9) | (68) |
| Gain before finance costs and taxation | 78 | 308 | 386 | |
| Finance costs | (20) | – | (20) | |
| Gain on ordinary activities before taxation | 58 | 308 | 366 | |
| Taxation | 3 | – | – | – |
| Gain attributable to ordinary shareholders | 58 | 308 | 366 | |
| Gain per Ordinary Share | 4 | 0.97p | 5.13p | 6.09p |
The Total column of this statement is the profit and loss account of the Fund. All revenue and capital items are derived from continuing operations. No operations were acquired or discontinued in the year. A Statement of Comprehensive Income is not required as all gains and losses of the Fund have been reflected in the above statement.
The Accounting Policies and the Notes on pages 34 to 40 form part of these Financial Statements
as at 31 March 2017
| 2017 | 2016 | ||
|---|---|---|---|
| Notes | £000 | £000 | |
| Fixed Assets | |||
| Investments at fair value through profit or loss | 5 | 5,583 | 4,628 |
| Current Assets | |||
| Debtors | 6 | 238 | 299 |
| Cash at bank and on deposit | 16 | 102 | |
| Total current assets | 254 | 401 | |
| Creditors: amounts falling due within one year | 7 | (177) | (137) |
| Net current assets | 77 | 264 | |
| Total assets less current liabilities | 5,660 | 4,892 | |
| Capital and Reserves | |||
| Share capital | 8 | 300 | 300 |
| Share premium | 314 | 314 | |
| Special reserve | 5,144 | 5,144 | |
| Capital redemption reserve | 27 | 27 | |
| Capital reserve | 311 | (399) | |
| Revenue reserve | (436) | (494) | |
| Equity shareholders' funds | 5,660 | 4,892 | |
| Net asset value per Ordinary Share | 4 | 94.25p | 81.47p |
Approved and authorised for issue by the Board of Directors on 30 June 2017 and signed on its behalf by Peter Dicks, Chairman.
Company registered number: SC211841
The Accounting Policies and the Notes on pages 34 to 40 form part of these Financial Statements
for the year to 31 March 2017
| Share capital £000 |
Share premium £000 |
reserve £000 |
Capital Special redemption reserve £000 |
Capital reserve £000 |
Revenue reserve £000 |
|
|---|---|---|---|---|---|---|
| As at 1 April 2016 | 300 | 314 | 5,144 | 27 | (399) | (494) |
| Gain attributable to shareholders |
– | – | – | – | 710 | 58 |
| As at 31 March 2017 | 300 | 314 | 5,144 | 27 | 311 | (436) |
For the year to 31 March 2016
| Share capital £000 |
Share premium £000 |
Special reserve £000 |
Capital redemption reserve £000 |
Capital reserve £000 |
Revenue reserve £000 |
|
|---|---|---|---|---|---|---|
| As at 1 April 2015 | 300 | 314 | 5,144 | 27 | (707) | (552) |
| Gain attributable to shareholders |
– | – | – | – | 308 | 58 |
| As at 31 March 2016 | 300 | 314 | 5,144 | 27 | (399) | (494) |
for the year to 31 March 2017
| 2017 £000 |
2016 £000 |
|
|---|---|---|
| Operating Activities | ||
| Gain before finance costs and taxation | 784 | 386 |
| Adjusted for: | ||
| (Gains) on investments | (717) | (317) |
| Transaction costs | 7 | 9 |
| Taxation recovered | 1 | – |
| Movement in debtors | 61 | (279) |
| Movement in other creditors | 1 | (2) |
| Cash flow from operating activities | 137 | (203) |
| Financing activities Finance costs |
(17) | (20) |
| Cash flow from financing activities | (17) | (20) |
| Investment activities | ||
| Purchases of fixed asset investments | (2,110) | (2,702) |
| Sales of fixed asset investments | 1,881 | 2,896 |
| Cash flow from investing activities | (229) | 194 |
| Movement in cash, cash equivalent and bank overdraft | (109) | (29) |
| Cash and cash equivalent as at start of the year | 102 | 131 |
| Cash, cash equivalent and bank overdraft as at end of the year | (7) | 102 |
The Accounting Policies and the Notes on pages 34 to 40 form part of these Financial Statements
The Financial Statements have been prepared on a going concern basis in accordance with FRS 102, the "Financial Reporting Standard applicable in the UK and Republic of Ireland" and under the AIC's Statement of Recommended Practice "Financial Statements of Investment Trust Companies and Venture Capital Trusts" (SORP) issued in 2014.
Preparation of financial statements can require management to make significant judgements and estimates. There are no significant judgements or sources of estimation uncertainty the Board considers need to be disclosed.
Income is included in the Income Statement on an ex-dividend basis. Income on fixed interest securities is included on an effective interest rate basis. Deposit interest is included on an accruals basis.
Expenses and interest payable are dealt with on an accruals basis.
Investment management fees, if any, are allocated 100 per cent to capital. The allocation is in line with the Board's expected long-term return from the investment portfolio. Due to the size of the Fund, the Manager has waived its management fee. The terms of the investment management agreement are detailed in the Report of the Directors.
Current tax is provided at the amounts expected to be paid or received. Deferred taxation is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more or a right to pay less tax in the future have occurred at the balance sheet date measured on an undiscounted basis and based on enacted tax rates. This is subject to deferred tax assets only being recognised if it is considered more likely than not that there will be suitable profits from which the future reversal of the underlying timing differences can be deducted. Timing differences are differences arising between the taxable profits and the results as stated in the financial statements which are capable of reversal in one or more subsequent periods.
The investments have been categorised as ''fair value through profit or loss''. All investments are held at fair value. For listed investments this is deemed to be at bid prices. Contracts for Differences are synthetic equities and are valued with reference to the investment's underlying bid prices. Unlisted investments are valued at fair value based on the latest available information and with reference to International Private Equity and Venture Capital Valuation Guidelines. All changes in fair value and transaction costs on the acquisition and disposal of portfolio investments are included in the Income Statement as a capital item. Purchases and sales of investments are accounted for on trade date.
In addition to the investment transactions described above, basic financial instruments are entered into that result in recognition of other financial assets and liabilities, such as investment income due but not received, other debtors and other creditors. These financial instruments are receivable and payable within one year and are stated at cost less impairment.
Transactions involving foreign currencies are converted at the rate ruling as at the date of the transaction. Foreign currency monetary assets and liabilities are retranslated into sterling at the rate ruling on the financial reporting date.
Gains and losses on realisations of fixed asset investments, and transactions costs, together with appropriate exchange differences, are dealt with in this reserve. All incentive fees and investment management fees, together with any tax relief, is also taken to this reserve. Increases and decreases in the valuation of fixed asset investments are dealt with in this reserve.
| 2017 £000 |
2016 £000 |
|
|---|---|---|
| 1. Income | ||
| Income from shares and securities | ||
| – dividends | 138 | 137 |
| – interest | – | – |
| 138 | 137 | |
| 2. Other expenses | ||
| Revenue | ||
| General expenses | 32 | 28 |
| Directors' fees | 18 | 18 |
| Auditor's remuneration – audit services | 13 | 12 |
| – taxation services | 1 | 1 |
| 64 | 59 | |
| Capital | ||
| Transaction costs – acquisitions | 4 | 4 |
| – disposals | 3 | 5 |
| 7 | 9 | |
| 3. Taxation | ||
| Current taxation | (1) | – |
| Deferred taxation | – | – |
| Total taxation charge for the year | (1) | – |
| The tax assessed for the year is different from the standard small company rate of corporation tax in | ||
| the UK. The differences are noted below: | ||
| Gain on ordinary activities before taxation | 767 | 366 |
| Corporation tax (20%, 2016 – 20%) | 153 | 73 |
| Non taxable UK dividends | (25) | (25) |
| Non taxable investment (gains)/losses in capital | (142) | (61) |
| Movement in unutilised management expenses and NTLR deficits | 13 | 13 |
| Total taxation charge for the year | (1) | – |
At 31 March 2017, the Fund had unutilised management expenses and non trade loan relationship ("NTLR") deficits of £957,000 (2016 – £927,000).
A deferred tax asset of £191,000 (2016 – £185,000) has not been recognised on the unutilised management expenses as it is unlikely that there would be suitable taxable profits from which the future reversal of the deferred tax asset could be deducted.
Returns per share are based on a weighted average of 6,005,000 (2016 – 6,005,000) ordinary shares in issue during the year.
Total return per share is based on the total gain for the year of £768,000 (2016 – gain of £366,000).
Capital return per share is based on the net capital gain for the year of £710,000 (2016 – gain of £308,000).
Revenue return per share is based on the revenue gain after taxation for the year of £58,000 (2016 – gain of £58,000).
The net asset value per share is based on the net assets of the Fund of £5,660,000 (2016 – £4,892,000) divided by the number of shares in issue at the year end as shown in note 8.
| 2017 £000 |
2016 £000 |
|||
|---|---|---|---|---|
| 5. Investments at fair value through profit or loss | ||||
| Listed investments | 5,583 | 4,628 | ||
| Unlisted investments | – | – | ||
| Valuation as at end of year | 5,583 | 4,628 | ||
| Listed £000 |
Unlisted £000 |
Total £000 |
||
| Valuation as at start of year | 4,628 | – | 4,628 | 4,571 |
| Investment holding (gains)/losses as at start of year | 1,121 | (185) | 936 | (1,070) |
| Cost as at start of year | 3,507 | 185 | 3,692 | 3,501 |
| Purchases of investments at cost | 2,106 | – | 2,106 | 2,547 |
| Proceeds from sale of investments | (1,884) | – | (1,884) | (2,901) |
| Transfers | – | – | – | – |
| Net gain/(loss) on sale of investments | 113 | (50) | 63 | 545 |
| Cost as at end of year | 3,842 | 135 | 3,977 | 3,692 |
| Investment holding gains/(losses) as at end of year |
1,741 | (135) | 1,606 | 936 |
| Valuation as at end of year | 5,583 | – | 5,583 | 4,628 |
| Net gain/(loss) on sale of investments | 113 | (50) | 63 | 545 |
| Movement in investment holding gains | 654 | – | 654 | (228) |
| Total gain/(loss) on investments | 767 | (50) | 717 | 317 |
| 2017 £000 |
2016 £000 |
|||
| 6. Debtors | ||||
| Investment income due but not received | 9 | 9 | ||
| Amounts receivable relating to CFDs | 229 | 290 | ||
| Taxation | – | – | ||
| 238 | 299 |
| 2017 | 2016 | |
|---|---|---|
| £000 | £000 | |
| 7. Creditors: amounts falling due within one year | ||
| Bank overdraft | 23 | – |
| Amounts due relating to CFDs | 132 | 116 |
| Other creditors | 22 | 21 |
| 177 | 137 | |
| 8. Share capital | ||
| Allotted, issued and fully paid | ||
| 6,005,000 ordinary 5p shares (2016 – same) | 300 | 300 |
As at the date of publication of this document, there was no change in the issued share capital and each ordinary share carries one vote.
The Fund's investment policy is to hold investments, CFDs and cash balances with gearing being provided by a bank overdraft. All investments are denominated in Sterling and are carried at fair value. Where appropriate, gearing can be utilised in order to enhance net asset value. It does not invest in short dated fixed rate securities other than where it has substantial cash resources. Fixed rate securities held at 31 March 2017 were valued at £nil (2016 – £nil). Investments, which comprise principally equity investments, are valued as detailed in the accounting policies.
The Fund only operates short term gearing, which is limited to 30 per cent of gross assets, and is undertaken through an unsecured variable rate bank overdraft and the use of CFDs. The benchmark rate which determines the interest received on Sterling cash balances or paid on bank overdrafts is the bank base rate which was 0.25% as at 31 March 2017 (2016 – 0.5%). There are no undrawn committed borrowing facilities. Short-term debtors and creditors are excluded from disclosure.
The Fund does not have any direct foreign currency exposure and is consequently not currency hedged. Financial information on the investment portfolio is detailed in note 5.
| 2017 | 2016 | |
|---|---|---|
| £000 | £000 | |
| Classification of financial instruments | ||
| Level 1 | 5,472 | 4,594 |
| Level 2 | 111 | 34 |
| Level 3 – 2 investments (2016 – 3) | – | – |
Level 1 reflects financial instruments quoted in an active market.
Level 2 reflects financial instruments whose fair value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets. The CFD positions are the sole Level 2 investments for 2017 and 2016.
Level 3 reflects financial instruments whose fair value is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.
The movements within level 3 investments were as follows:
| 2017 £000 |
2016 | |
|---|---|---|
| £000 | ||
| Valuation as at start of year | – | 30 |
| Purchases of investments at cost | – | – |
| Proceeds from sale of investments | – | – |
| Net losses on sale of investments | (50) | – |
| Transfers | – | – |
| Movement in investment holding gains | 50 | (30) |
| Valuation as at end of year | – | – |
The Board has granted the Manager a limited authority to invest in CFDs to achieve some degree of gearing and/or hedging without incurring the gross cost of investment. The Board requires the Manager to operate within certain risk limits, as detailed in the Report of the Directors. The following table details the CFD positions:
Number of holdings (2017 – 16; 2016 – 16)
| Gross exposure | 1,342 | 1,335 |
|---|---|---|
| Net exposure | 1,342 | 1,335 |
| Unrealised gains | 111 | 34 |
| Unrealised losses | 132 | 116 |
The major risks inherent within the Fund are market risk, liquidity risk, credit risk and interest rate risk. It has an established environment for the management of these risks which are continually monitored by the Manager. Appropriate guidelines for the management of its financial instruments and gearing have been established by the Board of Directors. It has no foreign currency assets and therefore does not use currency hedging. It does not use derivatives within the portfolio with the exception of CFDs.
The risk that the Fund may suffer a loss arising from adverse movements in the fair value or future cash flows of an investment. Market risks include changes to market prices, interest rates and currency movements. The Fund invests in a diversified portfolio of holdings covering a range of sectors. The Manager conducts continuing analysis of holdings and their market prices with an objective of maximising returns to shareholders. Asset allocation, stock selection and market movements are reported to the Board on a regular basis.
The risk that the Fund may encounter difficultly in meeting obligations associated with financial liabilities. The Fund is permitted to invest in shares traded on AIM or similar markets; these tend to be in companies that are smaller in size and by their nature less liquid than larger companies. The Manager conducts continuing analysis of the liquidity profile of the portfolio and the Fund maintains an overdraft facility to ensure that it is not a forced seller of investments.
The risk that the counterparty to a transaction fails to discharge its obligation or commitment to the transaction resulting in a loss to the Fund. Investment transactions are entered into using brokers that are on the Manager's approved list, the credit ratings of which are reviewed periodically in addition to an annual review by the Manager's board of directors. The Fund's principal bankers are State Street Bank & Trust Company, the main broker for CFDs is UBS and other approved execution broker organisations authorised by the Financial Conduct Authority.
The risk that interest rate movements may affect the level of income receivable on cash deposits. At most times the Fund operates with relatively low levels of bank gearing, this has and will only be increased where an opportunity exists to substantially add to the net asset value performance.
The following table details the impact on net asset value and return per share of the Fund to changes in the two principal drivers of performance, namely investment returns and interest rates. The calculations are based on the balances at the respective balance sheet dates and are not representative of the year as a whole.
| 2017 | 2016 | |
|---|---|---|
| £000 | £000 | |
| Investment portfolio | ||
| 5% increase | +5.7p | +4.9p |
| 5% decrease | -5,7p | -4.9p |
| Other assets/liabilities | ||
| Interest rate 0.5% increase | – | – |
| Interest rate 0.5% decrease | – | – |
| Maximum credit risk analysis | ||
| As at the year end, the Fund's maximum credit risk exposure was as follows: | ||
| Bank | 16 | 102 |
| Amounts receivable relating to CFDs | 229 | 290 |
| Investment income due but not received | 9 | 9 |
| Taxation | – | – |
| 254 | 401 |
Contractual maturity analysis
| Due not later than 1 month £000 |
Due between 1 and 3 months £000 |
Due between 3 and 12 months £000 |
2017 Total £000 |
|
|---|---|---|---|---|
| Bank | 16 | – | – | 16 |
| Debtors | 6 | 3 | 229 | 238 |
| Creditors | (177) | – | – | (177) |
| Net liquidity | (155) | 3 | 229 | 77 |
| Due not | Due | Due | |
|---|---|---|---|
| later than | between 1 and | between 3 and | 2016 |
| 1 month | 3 months | 12 months | Total |
| £000 | £000 | £000 | £000 |
| 102 | – | – | 102 |
| 8 | 1 | 290 | 299 |
| (137) | – | – | (137) |
| (27) | 1 | 264 | |
| 290 |
Cash flows payable under financial liabilities by remaining contractual liabilities are as stated above.
The Fund's management objectives are to provide shareholders with long term capital growth.
| 2017 | 2016 | |
|---|---|---|
| £000 | £000 | |
| Capital and reserves: | ||
| Share capital | 300 | 300 |
| Share premium | 314 | 314 |
| Special reserve | 5,144 | 5,144 |
| Capital redemption reserve | 27 | 27 |
| Capital reserve | 311 | (494) |
| Revenue reserve | (436) | (399) |
| Total shareholders' funds | 5,660 | 4,892 |
The Fund's objectives for managing capital are detailed in the Strategic Report and have been complied with throughout the year. It normally restricts gearing to 30% of net assets, maintaining a minimum share capital of £50,000 (as a public company) and adheres to the capital restrictions imposed by relevant company and tax legislation.
The revenue reserve is distributable and, to the extent it is positive, dividends can be funded from it. The special reserve is distributable and the cost of purchasing own shares has been accounted for in this reserve. The Company's Articles of Association prohibit the distribution of capital profits by way of dividend.
The Management section of the Report of the Directors sets out the services provided by the Manager to the Fund and fees earned. In view of the size of the Fund, the Manager has waived its management fees for the years to 31 March 2017 and 31 March 2016. The share interests of the Manager in the Fund are set out in the Substantial shareholdings section of the Report of the Directors. C W McLean is managing director of SVM Asset Management Limited.
There are no transactions with Directors other than aggregated remuneration for services as Directors as disclosed in the Directors' Remuneration Report and note 2. Shareholdings of Directors are also set out in the Directors' Remuneration Report.
NOTICE IS HEREBY GIVEN that an Annual General Meeting of SVM UK Emerging Fund plc ('the Company') will be held at the offices of SVM Asset Management Limited, 7 Castle Street, Edinburgh, EH2 3AH on Friday, 15 September 2017 at 9.30 am to consider and, if thought fit, pass the following resolutions of which resolutions 1 – 8 will be proposed as Ordinary Resolutions and Resolutions 9 & 10 as Special Resolutions all as set out below.
Authority to allot shares
That, in substitution for any existing authority, but without prejudice to the exercise of that authority prior to the date hereof, the Directors of the Company are hereby authorised in accordance with Section 551 of the Companies Act 2006 to exercise all the powers of the Company to allot shares in the Company and to grant rights to subscribe for shares in the Company provided that such authority shall be limited to the allotment of shares and the grant of rights in respect of shares with an aggregate nominal value not exceeding £30,000, representing approximately 10% of the nominal value of the issued capital of the Company and provided that said authority shall expire at the conclusion of the next general meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, unless previously revoked, varied or extended by the Company in a general meeting, save that the Company may at any time prior to the expiry of this authority make an offer or enter into an agreement which would or might require shares to be allotted or granted after the expiry of this authority and the Directors shall be entitled to allot or grant shares pursuant to said offer or agreement as if this authority had not expired.
accordance with section 701 of Companies Act 2006 to make market purchases (within the meaning of section 693 thereof) of shares of the Company provided that:
That, the Directors be authorised to allot shares in the Company for cash either pursuant to the authority conferred by resolution 8 above or by way of sale of treasury shares as if Section 561(1) of the Companies Act 2006 did not apply to such allotment, provided that this authority shall be limited to the allotment of shares with an aggregate nominal value not exceeding £30,000 representing approximately 10% of the nominal value of the issued share capital of the Company. The Directors of the Company are hereby authorised for the purposes of LR15.4.11 of the Listing Rules of the UK Listing Authority of the Financial Conduct Authority to sell treasury shares for cash at a price below the net asset value per share of those shares without any prior offer to Shareholders of the Company. This authority shall expire at the conclusion of the next general meeting of the Company after the passing of this resolution or on the expiry of 15 months from the passing of this resolution, whichever is the earlier, save that the Company may, before such expiry, make an offer or agreement which would or might require shares to be allotted after such expiry and the Directors may allot shares pursuant to any such offer or agreement as if the authority conferred hereby had not expired.
By order of the Board SVM Asset Management Limited Company Secretary
30 June 2017
of receipt will be taken to be the time (as determined by the timestamp applied to the message by the CREST Application Host) from which the Company's registrar is able to retrieve the message by enquiry to CREST in the manner prescribed by CREST. After this time any change of instructions to proxies appointed through CREST should be communicated to the appointee through other means. CREST members and, where applicable, their CREST sponsors, or voting service providers should note that Euroclear UK & Ireland Limited does not make available special procedures in CREST for any particular message. Normal system timings and limitations will, therefore, apply in relation to the input of CREST Proxy Instructions. It is the responsibility of the CREST member concerned to take (or, if the CREST member is a CREST personal member, or sponsored member, or has appointed a voting service provider(s), to procure that his CREST sponsor or voting service provider(s) take(s)) such action as shall be necessary to ensure that a message is transmitted by means of the CREST system by any particular time. In this connection, CREST members, and where applicable, their CREST sponsors or voting service provider(s) are referred, in particular, to those sections of the CREST Manual concerning practical limitations of the CREST system and timings. The Company may treat as invalid a CREST Proxy Instruction in the circumstances set out in Regulation 35(5)(a) of the Uncertificated Securities Regulations 2001.
The SVM website remains the best source of information about the Fund. Over recent years, there have been a number of initiatives which have been added to improve shareholder access and the quality of reporting and marketing. These initiatives attract new investors and keep existing shareholders informed.
The Fund's latest share price is updated daily and gives access to historical share price data since launch.
An interactive charting tool allows investors to view the performance record over fixed time periods or dates of their choice.
There is no longer any requirement to post the Fund's half yearly report to shareholders. It is made available on the website together with all other information we publish for the Fund.
Comprehensive quarterly factsheets are produced with the Manager's commentary, portfolio analysis, featured stock, fund performance, sector breakdowns and current hedging and gearing status.
The Fund distributes quarterly updates by email to a number of intermediaries. It is also possible for shareholders and other interested parties to subscribe to this. To do so, please email your request to [email protected]
At SVM, we aim to achieve superior investment performance through careful stock picking and analysis. Whether we are researching for our long or long/short funds we undertake proprietary, in-depth analysis in order to identify the true value of a company or fund. This strategy has ensured that we have achieved superior investment returns for a broad range of clients – both institutional and private investors. As pure equity specialists, we focus our expertise on investing in UK and European companies as well as global investment funds.
Shares can be easily traded on the London Stock Exchange.
Investors wishing to purchase shares in the Fund or sell all or part of their existing holding may do so through a stockbroker or their other financial adviser. Most banks also offer this service. It is also possible to trade the Company's shares through many of the online dealing service providers.
For more information the Manager can be contacted on 0131 226 7660 or alternatively information is available on the website: www.svmonline.co.uk. The Manager is not permitted to give you financial or tax advice. If you are in any doubt please consult your financial adviser.
SVM Asset Management Limited 6th Floor 7 Castle Street Edinburgh EH2 3AH Telephone: +44 (0) 131 226 6699 Facsimile: +44 (0) 131 226 7799 Email: [email protected] Web: www.svmonline.co.uk
Computershare Investor Services plc Leven House, 10 Lochside Place Edinburgh Park Edinburgh EH12 9DF Telephone: +44 (0) 370 702 0003
Scott-Moncrieff Exchange Place 3 Semple Street Edinburgh EH3 8BL
State Street Bank & Trust Company
SC211841
www.svmonline.co.uk
SVM Asset Management Limited 7 Castle Street Edinburgh EH2 3AH 0800 0199 440
www.svmonline.co.uk
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.